Lung Therapeutics, Inc.

📍 Austin, United States🗓 Founded 2013👥 25 employees💰 Last funded 2015
Biotechnology Research🌐 lungtx.com
Website LinkedIn
Headquartered in Austin, Texas, Lung Therapeutics, Inc. is a clinical stage biopharmaceutical company formed to leverage decades of leading research in orphan, pulmonary indications for which there are unmet medical needs. The company is developing a proprietary pipeline of therapeutics with the potential to greatly improve outcomes over currently available treatments. The company’s lead drug candidate, LTI-01, is in clinical development for Loculated Pleural Effusion (LPE) and has successfully completed a clinical trial in LPE patients. The company’s second drug candidate, LTI-03, is in clinical development for Idiopathic Pulmonary Fibrosis (IPF).
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2013
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Lung Therapeutics, Inc.?
Lung Therapeutics, Inc. has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Lung Therapeutics, Inc. last raise funding?
The most recent investment in Lung Therapeutics, Inc. recorded on gritt.io was in 2015.
When was Lung Therapeutics, Inc. founded?
Lung Therapeutics, Inc. was founded in 2013.
What industry is Lung Therapeutics, Inc. in?
Lung Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Lung Therapeutics, Inc. based?
Lung Therapeutics, Inc. is headquartered in Austin, United States.